Trump Stays Silent on Abortion Pill Case as DOJ Skips Supreme Court Brief 6 Months Before Midterms
Updated
Updated · The New York Times · May 18
Trump Stays Silent on Abortion Pill Case as DOJ Skips Supreme Court Brief 6 Months Before Midterms
7 articles · Updated · The New York Times · May 18
Six months before the midterms, Trump has stayed silent on a lawsuit threatening access to mifepristone, even after the case reached the Supreme Court.
The Justice Department also declined to file a brief defending the FDA — an unusual move in litigation over a drug the agency regulates.
Louisiana's suit had prompted a federal appeals court to temporarily block telemedicine prescriptions and mail delivery of the pill.
The Supreme Court twice paused that ruling and last week restored telemedicine and mail access indefinitely while the case continues in lower courts.
The episode underscores Republicans' political strain on abortion 4 years after Roe was overturned, with the procedure still widely available and annual abortions slightly higher.
How could this legal fight over one pill reshape the future of all FDA-approved medicines?
With a 19th-century law in a modern court case, what is the future of medication by mail?
What are the unseen economic costs when legal challenges disrupt access to established medical care?